While we attained success in the acute phase of DMD in alleviating muscle necrosis, it is vital that we explore the long-term effects of PGD2 inhibition and its effect in the cardiac and respiratory system, as these are vital organs that depreciate in the chronic phase of DMD [53]. The gene discussed is PTGDS; the disease is Duchenne muscular dystrophy.